ADMA Biologics, Inc.
ADMA
$20.64
$0.9955.07%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 18.96% | -1.74% | 94.69% | -11.74% | -30.75% |
Total Receivables | -0.28% | 66.51% | -39.31% | 80.96% | -12.45% |
Inventory | -0.91% | -4.45% | 1.17% | 2.79% | 6.00% |
Prepaid Expenses | -15.88% | 72.79% | 47.66% | -29.87% | 4.43% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 4.15% | 4.78% | 9.87% | 7.55% | -6.10% |
|
|||||
Total Current Assets | 4.15% | 4.78% | 9.87% | 7.55% | -6.10% |
Net Property, Plant & Equipment | 1.20% | -1.40% | -1.91% | 1.96% | -1.70% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
Total Other Intangibles | -5.15% | 1.25% | 49.22% | -35.67% | 4.63% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1,445.57% | 11.45% | -11.37% | 26.15% | -30.53% |
Total Assets | 25.10% | 3.78% | 7.27% | 6.59% | -5.68% |
|
|||||
Total Accounts Payable | 26.21% | 12.98% | -17.50% | 9.74% | 44.31% |
Total Accrued Expenses | 18.20% | 7.17% | -27.82% | 2.47% | 12.12% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.10% | 4.47% | 4.48% | 4.59% | 6.32% |
Total Finance Division Other Current Liabilities | 58.39% | -44.73% | 78.79% | 37.38% | -7.59% |
Total Other Current Liabilities | 58.39% | -44.73% | 78.79% | 37.38% | -7.59% |
Total Current Liabilities | 23.73% | 1.62% | -16.79% | 6.59% | 19.04% |
|
|||||
Total Current Liabilities | 23.73% | 1.62% | -16.79% | 6.59% | 19.04% |
Long-Term Debt | -28.61% | -22.70% | 0.17% | 0.19% | -8.05% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -3.43% | -3.45% | -3.21% | -2.99% | -1.87% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -11.68% | -1.38% | -1.33% | -1.32% | 1.86% |
Total Liabilities | -12.01% | -15.63% | -4.58% | 1.65% | -1.81% |
|
|||||
Common Stock & APIC | 0.80% | 1.20% | 0.39% | 0.11% | 0.22% |
Retained Earnings | 26.61% | 7.87% | 6.56% | 3.52% | -3.61% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 50.51% | 23.17% | 22.49% | 13.68% | -10.72% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 50.51% | 23.17% | 22.49% | 13.68% | -10.72% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 50.51% | 23.17% | 22.49% | 13.68% | -10.72% |
|